5 results
424B3
ME
23andMe Holding Co - Ordinary Shares
27 May 22
Prospectus supplement
4:52pm
, including recall. Once an approval is granted, the FDA may issue enforcement letters or withdraw the approval of the product if compliance with regulatory … may have to recall product and/or be subject to an FDA enforcement action. The process for resolving the inspectional observations and/or potential
424B3
ME
23andMe Holding Co - Ordinary Shares
23 Jul 21
Prospectus supplement
4:31pm
result in restrictions on a product, manufacturer or holder of an approved NDA or BLA, including recall. Once an approval is granted, the FDA may
- Prev
- 1
- Next